rs139458920

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_002566.5(P2RY11):​c.234C>A​(p.Cys78*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000089 in 1,460,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. C78C) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000089 ( 0 hom. )

Consequence

P2RY11
NM_002566.5 stop_gained

Scores

2
12

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.55

Publications

0 publications found
Variant links:
Genes affected
P2RY11 (HGNC:8540): (purinergic receptor P2Y11) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is coupled to the stimulation of the phosphoinositide and adenylyl cyclase pathways and behaves as a selective purinoceptor. Naturally occuring read-through transcripts, resulting from intergenic splicing between this gene and an immediately upstream gene (PPAN, encoding peter pan homolog), have been found. The PPAN-P2RY11 read-through mRNA is ubiquitously expressed and encodes a fusion protein that shares identity with each individual gene product. [provided by RefSeq, Jul 2008]
PPAN-P2RY11 (HGNC:33526): (PPAN-P2RY11 readthrough) This locus represents naturally occurring read-through transcription between the adjacent PPAN and P2RY11 genes. Alternative splicing results in two transcript variants, one of which encodes a fusion protein that shares sequence identity with each individual gene product. This transcript is found to be ubiquitously expressed and is up-regulated by agents inducing granulocytic differentiation. However, its functional significance in vivo remains unclear. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002566.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P2RY11
NM_002566.5
MANE Select
c.234C>Ap.Cys78*
stop_gained
Exon 2 of 2NP_002557.2
PPAN-P2RY11
NM_001040664.3
c.1494C>Ap.Cys498*
stop_gained
Exon 13 of 13NP_001035754.1A0A0B4J1V8
PPAN-P2RY11
NM_001198690.2
c.1556C>Ap.Ala519Glu
missense
Exon 13 of 13NP_001185619.1A0A0A6YYI3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P2RY11
ENST00000321826.5
TSL:1 MANE Select
c.234C>Ap.Cys78*
stop_gained
Exon 2 of 2ENSP00000323872.4Q96G91
PPAN-P2RY11
ENST00000393796.4
TSL:1
c.1494C>Ap.Cys498*
stop_gained
Exon 13 of 13ENSP00000377385.4A0A0B4J1V8
PPAN-P2RY11
ENST00000428358.5
TSL:2
c.1556C>Ap.Ala519Glu
missense
Exon 13 of 13ENSP00000411918.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000890
AC:
13
AN:
1460592
Hom.:
0
Cov.:
32
AF XY:
0.0000124
AC XY:
9
AN XY:
726582
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33464
American (AMR)
AF:
0.00
AC:
0
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86214
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52820
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000108
AC:
12
AN:
1111564
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
19
DANN
Benign
0.94
Eigen
Benign
-0.55
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.19
T
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-0.32
T
PhyloP100
-4.6
PROVEAN
Benign
0.14
N
REVEL
Benign
0.090
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.18
MutPred
0.14
Gain of solvent accessibility (P = 0.0456)
MVP
0.17
ClinPred
0.49
T
GERP RS
-8.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=91/109
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139458920; hg19: chr19-10224523; API